G1-S (Sema) is a research compound widely studied for its role in appetite regulation, glucose metabolism, and energy balance pathways. It is commonly positioned as a foundational compound in metabolic and weight-regulation research models, serving as an entry point for GLP-1 receptor-focused investigations.
As a GLP-1 receptor agonist, G1-S is often studied for its effects on appetite signaling pathways, insulin response, and gastric emptying. Its extended half-life and once-weekly dosing make it a reference compound in long-term metabolic and endocrine research protocols, often preceding more complex dual- or triple-agonist studies.
Appetite signaling and intake regulation pathways
Satiety signaling and delayed gastric emptying mechanisms
Insulin response modulation and glucose stability
Metabolic efficiency and fat mass-related research
Energy balance and glycemic control pathways
G1-S functions by mimicking the activity of endogenous GLP-1, a hormone involved in glucose-dependent insulin secretion, appetite signaling, and digestive rate modulation. Research has shown that GLP-1 receptor activation influences central nervous system signaling related to food intake while also affecting peripheral glucose regulation.
Rather than acting as a direct satiety agent, G1-S is studied for its role in modulating neurohormonal pathways associated with appetite suppression, delayed gastric emptying, and metabolic signaling. These mechanisms have made it a cornerstone compound in metabolic research and a baseline comparator in GLP-1-related studies.
Extensive clinical and laboratory research has established G1-S as a well-characterized compound within the GLP-1 class, frequently utilized in ongoing metabolic and endocrine investigations.
Compound Class: GLP-1 receptor agonist
Administration Route: Subcutaneous injection
Molecular Formula: C187H291N45O59
Molecular Formula: C₁₈₇H₂₉₁N₄₅O₅₉
Molecular Weight: Approximately 4113.58 g mol
Half-Life: Approximately 7 days
Research Application: Metabolic and glucose regulation studies
SlimFit Compounds partners with emerging U.S.-based manufacturers that adhere to strict production, verification, and purity standards. These research-grade formulations are produced using protocols comparable to those employed by major pharmaceutical laboratories, enabling access to high-quality compounds without excessive cost barriers.
This product is intended for research and laboratory use only.
Not for human consumption.
Not intended to diagnose, treat, cure, or prevent any disease.
Information provided is for educational and research reference purposes only and has not been evaluated by the FDA. Only qualified professionals should handle this compound in appropriate research or laboratory settings.
G1-S (Sema) is a research compound widely studied for its role in appetite regulation, glucose metabolism, and energy balance pathways. It is commonly positioned as a foundational compound in metabolic and weight-regulation research models, serving as an entry point for GLP-1 receptor-focused investigations.
As a GLP-1 receptor agonist, G1-S is often studied for its effects on appetite signaling pathways, insulin response, and gastric emptying. Its extended half-life and once-weekly dosing make it a reference compound in long-term metabolic and endocrine research protocols, often preceding more complex dual- or triple-agonist studies.
Appetite signaling and intake regulation pathways
Satiety signaling and delayed gastric emptying mechanisms
Insulin response modulation and glucose stability
Metabolic efficiency and fat mass-related research
Energy balance and glycemic control pathways
G1-S functions by mimicking the activity of endogenous GLP-1, a hormone involved in glucose-dependent insulin secretion, appetite signaling, and digestive rate modulation. Research has shown that GLP-1 receptor activation influences central nervous system signaling related to food intake while also affecting peripheral glucose regulation.
Rather than acting as a direct satiety agent, G1-S is studied for its role in modulating neurohormonal pathways associated with appetite suppression, delayed gastric emptying, and metabolic signaling. These mechanisms have made it a cornerstone compound in metabolic research and a baseline comparator in GLP-1-related studies.
Extensive clinical and laboratory research has established G1-S as a well-characterized compound within the GLP-1 class, frequently utilized in ongoing metabolic and endocrine investigations.
Compound Class: GLP-1 receptor agonist
Administration Route: Subcutaneous injection
Molecular Formula: C187H291N45O59
Molecular Formula: C₁₈₇H₂₉₁N₄₅O₅₉
Molecular Weight: Approximately 4113.58 g mol
Half-Life: Approximately 7 days
Research Application: Metabolic and glucose regulation studies
SlimFit Compounds partners with emerging U.S.-based manufacturers that adhere to strict production, verification, and purity standards. These research-grade formulations are produced using protocols comparable to those employed by major pharmaceutical laboratories, enabling access to high-quality compounds without excessive cost barriers.
This product is intended for research and laboratory use only.
Not for human consumption.
Not intended to diagnose, treat, cure, or prevent any disease.
Information provided is for educational and research reference purposes only and has not been evaluated by the FDA. Only qualified professionals should handle this compound in appropriate research or laboratory settings.
